Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections

Clinical trial NCT03426761 · COMPLETED

Trial details

NCT number: NCT03426761
Sponsor: Infectious Diseases Physicians, Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Bone Infection Osteomyelitis Septic Arthritis Joint Infection Prosthetic Joint Infection

Start date: 2018-01-25
Primary completion: 2022-12-31
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.